Session

H. pylori (Posters)

THE ROLE OF HELICOBACTER PYLORI INFECTION IN MICROBIOME VARIABILITY IN FUNCTIONAL DYSPEPSIA IN KARACHI, PAKISTAN
THE ROLE OF HELICOBACTER PYLORI INFECTION IN MICROBIOME VARIABILITY IN FUNCTIONAL DYSPEPSIA IN KARACHI, PAKISTAN

ESOMEPRAZOLE VERSUS VONOPRAZAN - BASED THERAPIES FOR HELICOBACTER PYLORI ERADICATION: A RETROSPECTIVE CLINICAL STUDY
ESOMEPRAZOLE VERSUS VONOPRAZAN - BASED THERAPIES FOR HELICOBACTER PYLORI ERADICATION: A RETROSPECTIVE CLINICAL STUDY

DIAGNOSIS, TREATMENT PATTERNS, AND EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION IN CHINA: STUDY DESIGN FOR A RETROSPECTIVE REAL-WORLD STUDY
DIAGNOSIS, TREATMENT PATTERNS, AND EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION IN CHINA: STUDY DESIGN FOR A RETROSPECTIVE REAL-WORLD STUDY

LEVOFLOXACIN + TETRACYCLINE QUADRUPLE REGIMEN FOR ERADICATION OF HELICOBACTER PYLORI: A MULTICENTER MULTINATIONAL RANDOMIZED CLINICAL TRIAL
LEVOFLOXACIN + TETRACYCLINE QUADRUPLE REGIMEN FOR ERADICATION OF HELICOBACTER PYLORI: A MULTICENTER MULTINATIONAL RANDOMIZED CLINICAL TRIAL

ASSESSMENT OF FIRST-LINE TREATMENT IN GREECE: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
ASSESSMENT OF FIRST-LINE TREATMENT IN GREECE: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

NON-BISMUTH QUADRUPLE CONCOMITANT TREATMENT FOR H. PYLORI ERADICATION: SYSTEMATIC REVIEW AND META-ANALYSIS
NON-BISMUTH QUADRUPLE CONCOMITANT TREATMENT FOR H. PYLORI ERADICATION: SYSTEMATIC REVIEW AND META-ANALYSIS

EXPERIENCE WITH RIFABUTIN-CONTAINING THERAPY IN 426 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH RIFABUTIN-CONTAINING THERAPY IN 426 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

ANTIBIOTIC RESISTANCE TRENDS OF HELICOBACTER PYLORI NAÏVE PATIENTS IN THE PERIOD 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ANTIBIOTIC RESISTANCE TRENDS OF HELICOBACTER PYLORI NAÏVE PATIENTS IN THE PERIOD 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)

BISMUTH QUADRUPLE THREE-IN-ONE SINGLE CAPSULE: 3 OR 4 TIMES DAILY? SUB-ANALYSIS OF THE SPANISH DATA OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
BISMUTH QUADRUPLE THREE-IN-ONE SINGLE CAPSULE: 3 OR 4 TIMES DAILY? SUB-ANALYSIS OF THE SPANISH DATA OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

FIRST-LINE EMPIRICAL H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 30,000 CASES OF THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)
FIRST-LINE EMPIRICAL H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 30,000 CASES OF THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)

EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

FIRST-LINE EMPIRICAL H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 30,000 CASES OF THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)
FIRST-LINE EMPIRICAL H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 30,000 CASES OF THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

ANTIBIOTIC RESISTANCE TRENDS OF HELICOBACTER PYLORI NAÏVE PATIENTS IN THE PERIOD 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ANTIBIOTIC RESISTANCE TRENDS OF HELICOBACTER PYLORI NAÏVE PATIENTS IN THE PERIOD 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

BISMUTH QUADRUPLE THREE-IN-ONE SINGLE CAPSULE: 3 OR 4 TIMES DAILY? SUB-ANALYSIS OF THE SPANISH DATA OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
BISMUTH QUADRUPLE THREE-IN-ONE SINGLE CAPSULE: 3 OR 4 TIMES DAILY? SUB-ANALYSIS OF THE SPANISH DATA OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

EXPERIENCE WITH RIFABUTIN-CONTAINING THERAPY IN 426 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH RIFABUTIN-CONTAINING THERAPY IN 426 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

NON-BISMUTH QUADRUPLE CONCOMITANT TREATMENT FOR H. PYLORI ERADICATION: SYSTEMATIC REVIEW AND META-ANALYSIS
NON-BISMUTH QUADRUPLE CONCOMITANT TREATMENT FOR H. PYLORI ERADICATION: SYSTEMATIC REVIEW AND META-ANALYSIS

H. pylori (Posters)  et al.

ASSESSMENT OF FIRST-LINE TREATMENT IN GREECE: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
ASSESSMENT OF FIRST-LINE TREATMENT IN GREECE: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

Item 21 - 40 / 64
1
2
3 4